Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact
Description
CONCLUSIONS: The obtained prevalence of AD-treated patients was consistent with previous face-to-face studies. In contrast with previous studies, rivastigmine, rather than donepezil, was the most frequent treatment. A decrease in the incidence of AD
